loadpatents
name:-0.032267808914185
name:-0.012732982635498
name:-0.015628099441528
Universite d'Evry-Val-d'Essonne Patent Filings

Universite d'Evry-Val-d'Essonne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Universite d'Evry-Val-d'Essonne.The latest application filed is for "new adeno-associated virus (aav) variants and uses thereof for gene therapy".

Company Profile
14.19.28
  • Universite d'Evry-Val-d'Essonne - Evry FR
  • UNIVERSITE D'EVRY-VAL-D'ESSONNE - Evry-Courcouronnes FR
  • Universite d'Evry-Val-d'Essonne - Evry Cedex FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
App 20220280655 - Zucman-Rossi; Jessica ;   et al.
2022-09-08
Acid-alpha Glucosidase Variants And Uses Thereof
App 20220275396 - MINGOZZI; FEDERICO ;   et al.
2022-09-01
Method for reducing the expression of NKCC1 in a subject
Grant 11,427,836 - Mingozzi , et al. August 30, 2
2022-08-30
Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction
App 20220228167 - RONZITTI; Giuseppe ;   et al.
2022-07-21
Methods and tools for purifying nucleic acids and using polymerized tubulin
Grant 11,384,351 - Pastre , et al. July 12, 2
2022-07-12
Production Of Large-sized Quasidystrophins Using Overlapping Aav Vectors
App 20220204574 - RICHARD; Isabelle ;   et al.
2022-06-30
Compositions and methods for improving viral vector efficiency
Grant 11,371,061 - Majdoul , et al. June 28, 2
2022-06-28
Correction of Beta-Thalassemia Phenotype by Genetically Engineered Hematopoietic Stem Cell
App 20220184137 - AMENDOLA; Mario ;   et al.
2022-06-16
Hybrid Promoters For Muscle Expression
App 20220162640 - RONZITTI; GIUSEPPE ;   et al.
2022-05-26
Bifunctional Vectors Allowing Bcl11a Silencing And Expression Of An Anti-sickling Hbb And Uses Thereof For Gene Therapy Of B-hemoglobinopathies
App 20220160788 - MICCIO; Annarita ;   et al.
2022-05-26
Acid-alpha glucosidase variants and uses thereof
Grant 11,339,406 - Mingozzi , et al. May 24, 2
2022-05-24
Combination treatment of sarcoglycanopathies
Grant 11,298,348 - Richard , et al. April 12, 2
2022-04-12
Expression Cassettes For Gene Therapy Vectors
App 20220042045 - BUJ BELLO; ANA ;   et al.
2022-02-10
Recombinant Vectors Suitable For The Treatment Of Ipex Syndrome
App 20220017919 - ANDRE; Isabelle ;   et al.
2022-01-20
Hybrid Regulatory Elements
App 20210346519 - MINGOZZI; FEDERICO ;   et al.
2021-11-11
Novel Polynucleotides Encoding A Human Fkrp Protein
App 20210338837 - RICHARD; Isabelle ;   et al.
2021-11-04
Mini-gde For The Treatment Of Glycogen Storage Disease Iii
App 20210292724 - RONZITTI; GIUSEPPE ;   et al.
2021-09-23
Compositions and methods for the treatment of nucleotide repeat expansion disorders
Grant 11,104,897 - Buj Bello , et al. August 31, 2
2021-08-31
Use of Syncytin for Targeting Drug and Gene Delivery to Lung Tissue
App 20210198636 - Galy; Anne ;   et al.
2021-07-01
System For Controlling Speed Transition And Thrust Vectorisation In A Multiple-shaped Nozzle By Secondary Injection
App 20210164418 - LEGER; Luc ;   et al.
2021-06-03
Method For Reducing The Expression Of Nkcc1 In A Subject
App 20210130847 - Mingozzi; Federico ;   et al.
2021-05-06
Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism
App 20210107948 - RICHARD; Isabelle ;   et al.
2021-04-15
Antisense Targeting Dynamin 2 And Use For The Treatment Of Centronuclear Myopathies And Neuropathies
App 20210095291 - BUJ BELLO; Ana Maria
2021-04-01
Combination Treatment Of Sarcoglycanopathies
App 20210059999 - RICHARD; Isabelle ;   et al.
2021-03-04
Treatment Of Spinal Muscular Atrophy
App 20200370069 - BUJ BELLO; ANA ;   et al.
2020-11-26
Treatment Of Glycogen Storage Disease Iii
App 20200289673 - MINGOZZI; FEDERICO ;   et al.
2020-09-17
Methods And Tools For Purifying Nucleic Acids And Using Polymerized Tubulin
App 20200239870A1 -
2020-07-30
Method For Preparing Phosphorylated Keto Polyols, Derivatives Thereof And Uses Thereof
App 20200208181A1 -
2020-07-02
Aminopyridine compounds useful as inhibitors of protein prenylation
Grant 10,654,838 - Peschanski , et al.
2020-05-19
Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics
Grant 10,591,486 - Pastre , et al.
2020-03-17
Acid-alpha Glucosidase Variants And Uses Thereof
App 20190390225 - MINGOZZI; FEDERICO ;   et al.
2019-12-26
Stable Pseudotyped Lentiviral Particles And Uses Thereof
App 20190300902 - GALY; Anne
2019-10-03
Compositions And Methods For Improving Viral Vector Efficiency
App 20180318447 - MAJDOUL; Saliha ;   et al.
2018-11-08
Compositions And Methods For The Treatment Of Nucleotide Repeat Expansion Disorders
App 20180100144 - BUJ BELLO; Ana Maria ;   et al.
2018-04-12
Novel Aminopyridine Compounds Useful As Inhibitors Of Protein Prenylation
App 20170305892 - PESCHANSKI; Marc ;   et al.
2017-10-26
Methods for the treatment of Leber congenital amaurosis
Grant 9,777,272 - Rozet , et al. October 3, 2
2017-10-03
Methods And Tools For Detecting Interactions In Eukaryotic Cells Using Microtubule Structures And Dynamics
App 20170242026 - PASTRE; David ;   et al.
2017-08-24
Functionalized Biochips For Spr-ms Coupling
App 20160377610 - DANIEL; Regis ;   et al.
2016-12-29
Methods for the treatment of leber congenital amaurosis
Grant 9,487,782 - Rozet , et al. November 8, 2
2016-11-08
Nanopore Sequencing Using Replicative Polymerases And Helicases
App 20160319344 - CROQUETTE; Vincent ;   et al.
2016-11-03
Methods for the treatment of Leber congenital amaurosis
Grant 9,012,425 - Rozet , et al. April 21, 2
2015-04-21
Polymer derived from linear polyethylenimine for gene transfer
Grant 8,658,150 - Cheradame , et al. February 25, 2
2014-02-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed